This study defines adaptive resistance mechanisms to KRAS-targeted therapy in PDAC, revealing both cell-state-dependent RTK rewiring and a conserved SFK adaptive signaling axis and provides a mechanistic rationale for either KRAS/pan-RAS or pan-RAS/SFK co-inhibition as strategies to improve responses to KRAS-targeted t...
Qing-Xiang Lin, Bo-Kai Song, C. Sander et al.· Cancer Research· 1 citation
Specific tyrosine residues within the PTPN11-N, LYN, and SYK-C SH2 domains are studied, finding that the PTPN11 N-terminal site (Y63) modulates the specificity, reducing binding of physiologically relevant substrates.
SpY-C is used as a classifier to annotate the human phosphoproteome and individual experiments, to explore the consequences of using super-SH2 domain reagents for pY enrichment, and to analyze the effects of mutations in altering pY site function.
Alekhya Kandoor, Anny Carolline Silva Oliveira, K. Machida et al.· bioRxiv· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.